The CDC has newly issued recommendations for the monovalent COVID booster targeting new strains for everyone older than 6 months of age. In addition, there are two new RSV vaccines, one for infants and one for adults. These illnesses account for high levels of hospitalizations while vaccination rates remain low.

The RSV vaccines are new this year and healthcare teams need to gain knowledge of recommendations, effectiveness, and side effects for these new agents. In addition, teams need to be made aware of new recommendations for the new COVID booster.

COVID vaccinations rates remain relatively low in KY (~69% having at least one dose) and there is misinformation around side effects and importance of vaccination with both COVID and RSV vaccines. Healthcare teams need to know how to address misinformation related to fall respiratory virus vaccines.

To view the accreditation information and to claim credit go to: https://www.cecentral.com/activity/24753

COVID-19 Vaccination Hesitancy

UK Healthcare CECentral PodcastsBy UKHealthcare CECentralJan 20, 2022